Skip to main content
Clinical Trials/NCT06099561
NCT06099561RecruitingNot Applicable

Svårbehandlat självskadebeteende-Vilka Insatser är Effektiva?

Region Skane1 site in 1 country30 target enrollmentStarted: September 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
30
Locations
1
Primary Endpoint
The World Health Organization Disability Assessment Schedule II (WHODAS 2.0)

Study Overview

Brief Summary

The aim of this project is to evaluate a novel treatment program for individuals with intractable and lethal self-harm.

The main questions are:

1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions?

The secondary research questions are:

2. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm?

3. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions?

4. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions?

5. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata?

6. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?

Detailed Description

Individuals with intractable, imminent and lethal self-harm often have multifaceted psychiatric symptoms, pervasive suffering, high mortality and a reduced level of daily functioning. Severe self-harm can lead to long periods of psychiatric inpatient care which can lead to reduced autonomy and aggravated self-harm. Effects of this care remain uncertain. The Swedish National Board of Welfare has provided National specialized medical care units for severe self-harm behaviour to three Swedish hospitals.

In one of this hospitals, Region Skåne, the intervention will be consultation-based. Individuals with intractable self-harm will be offered an assessment and review of all medical records which will result in a individualized intervention plan. Interventions include further assessments and supporting the existing treatment providers, families or caregivers. Recurring network-meetings will occur every three months as well as at he end of the intervention.

Data collection will include self-report measures as well as information from charts and national och regional registries.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Having tried or made serious attempt to try at least two different interventions with evidence to reduce self-harm, without sufficient reduction in suffering or self-harm

Exclusion Criteria

  • •Need for translation services to complete measures or interviews
  • •Not able to complete measures or interviews

Arms & Interventions

Study group

Individuals with current severe, imminent and lethal self-harm with a history of at least two interventions without sufficient reduction of self-harm or suffering.

Intervention: National specialized medical care unit for severe self-harm behaviour-Consultation model (Behavioral)

Outcomes

Primary Outcomes

The World Health Organization Disability Assessment Schedule II (WHODAS 2.0)

Time Frame: Monthly from baseline to endpointat 24 months and at follow-up at 36 months.

Level of daily functioning and disability in the domains of cognition, mobility, self-care, getting along with other people and life activities.

Secondary Outcomes

  • Cost effectiveness(Monthly from baseline to endpointat 24 months and at follow-up at 36 months.)
  • Five Self-harm behaviour groupings measure (5S-HM)(Weekly from baseline to endpointat 24 months and at follow-up at 36 months.)
  • The 5-level EQ-5D(Monthly from baseline to endpointat 24 months and at follow-up at 36 months.)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials